StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)

Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%

Zoetis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zoetis's price to sales ratio was 3.6× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 3.0× to 15.2×, with a median of 8.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.6×−2.3
2025Dec 31, 20255.9×−2.1
2024Dec 31, 20248.0×−2.8
2023Dec 29, 202310.8×+2.3
2022Dec 30, 20228.5×−6.6
2021Dec 31, 202115.2×+3.1
2020Dec 31, 202012.0×+1.8
2019Dec 31, 201910.3×+3.1
2018Dec 31, 20187.2×+0.3
2017Dec 29, 20176.9×+1.4
2016Dec 30, 20165.4×+0.5
2015Dec 31, 20155.0×+0.4
2014Dec 31, 20144.6×+0.9
2013Dec 31, 20133.6×–

More Zoetis figures

See a number that looks wrong?